104 related articles for article (PubMed ID: 9427629)
1. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK.
Yu W; Fantl WJ; Harrowe G; Williams LT
Curr Biol; 1998 Jan; 8(1):56-64. PubMed ID: 9427629
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts.
Janssen RA; Kim PN; Mier JW; Morrison DK
Mol Cell Biol; 2003 Mar; 23(5):1786-97. PubMed ID: 12588996
[TBL] [Abstract][Full Text] [Related]
3. Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling.
Rock S; Li X; Song J; Townsend CM; Weiss HL; Rychahou P; Gao T; Li J; Evers BM
PLoS One; 2019; 14(3):e0211134. PubMed ID: 30917119
[TBL] [Abstract][Full Text] [Related]
4. Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.
Chow A; Khan ZM; Marsiglia WM; Dar AC
Methods Enzymol; 2022; 667():365-402. PubMed ID: 35525547
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Ca
Thines L; Jang H; Li Z; Sayedyahossein S; Maloney R; Nussinov R; Sacks DB
Protein Sci; 2024 May; 33(5):e4982. PubMed ID: 38591710
[TBL] [Abstract][Full Text] [Related]
6. A guide to ERK dynamics, part 1: mechanisms and models.
Ram A; Murphy D; DeCuzzi N; Patankar M; Hu J; Pargett M; Albeck JG
Biochem J; 2023 Dec; 480(23):1887-1907. PubMed ID: 38038974
[TBL] [Abstract][Full Text] [Related]
7. Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A; Cobb MH
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892237
[TBL] [Abstract][Full Text] [Related]
8. KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors.
Paniagua G; Jacob HKC; Brehey O; García-Alonso S; Lechuga CG; Pons T; Musteanu M; Guerra C; Drosten M; Barbacid M
Mol Oncol; 2022 Sep; 16(17):3066-3081. PubMed ID: 35313064
[TBL] [Abstract][Full Text] [Related]
9. RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.
Touboul R; Baritaki S; Zaravinos A; Bonavida B
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944867
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin influences MAPK signaling by binding KSR1.
Parvathaneni S; Li Z; Sacks DB
J Biol Chem; 2021; 296():100577. PubMed ID: 33766558
[TBL] [Abstract][Full Text] [Related]
11. Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.
Patterson VL; Burdine RD
Birth Defects Res; 2020 Jun; 112(10):749-765. PubMed ID: 32506834
[TBL] [Abstract][Full Text] [Related]
12. Time-resolved mapping of genetic interactions to model rewiring of signaling pathways.
Heigwer F; Scheeder C; Miersch T; Schmitt B; Blass C; Pour Jamnani MV; Boutros M
Elife; 2018 Dec; 7():. PubMed ID: 30592458
[TBL] [Abstract][Full Text] [Related]
13. Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.
Germino EA; Miller JP; Diehl L; Swanson CJ; Durinck S; Modrusan Z; Miner JH; Shaw AS
PLoS One; 2018; 13(3):e0194998. PubMed ID: 29596465
[TBL] [Abstract][Full Text] [Related]
14. Ras-Mediated Activation of the Raf Family Kinases.
Terrell EM; Morrison DK
Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29358316
[TBL] [Abstract][Full Text] [Related]
15. Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization.
Verlande A; Krafčíková M; Potěšil D; Trantírek L; Zdráhal Z; Elkalaf M; Trnka J; Souček K; Rauch N; Rauch J; Kolch W; Uldrijan S
EMBO Rep; 2018 Feb; 19(2):320-336. PubMed ID: 29263201
[TBL] [Abstract][Full Text] [Related]
16. Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras.
Frodyma D; Neilsen B; Costanzo-Garvey D; Fisher K; Lewis R
F1000Res; 2017; 6():1621. PubMed ID: 29026529
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of ERK1/2 regulation in smooth muscle involving acetylation of the ERK1/2 scaffold IQGAP1.
Vetterkind S; Lin QQ; Morgan KG
Sci Rep; 2017 Aug; 7(1):9302. PubMed ID: 28839270
[TBL] [Abstract][Full Text] [Related]
18. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
Stefan E; Bister K
Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
[TBL] [Abstract][Full Text] [Related]
19. KSR as a therapeutic target for Ras-dependent cancers.
Neilsen BK; Frodyma DE; Lewis RE; Fisher KW
Expert Opin Ther Targets; 2017 May; 21(5):499-509. PubMed ID: 28333549
[TBL] [Abstract][Full Text] [Related]
20. Negative feedback regulation of the ERK1/2 MAPK pathway.
Lake D; Corrêa SA; Müller J
Cell Mol Life Sci; 2016 Dec; 73(23):4397-4413. PubMed ID: 27342992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
